|
|
|
|
| LEADER |
01684nam a22003375i 4500 |
| 001 |
000280850 |
| 005 |
20210719092313.0 |
| 007 |
cr nn 008mamaa |
| 008 |
160511s2016 xxu| s |||| 0|eng d |
| 020 |
|
|
|a 9781493935543
|
| 024 |
7 |
|
|a 10.1007/978-1-4939-3554-3
|2 doi
|
| 040 |
|
|
|a Sistema de Bibliotecas del Tecnológico de Costa Rica
|
| 245 |
1 |
0 |
|a Genetics of Melanoma /
|c edited by Carlos A. Torres-Cabala, Jonathan L. Curry.
|
| 250 |
|
|
|a 1st ed. 2016.
|
| 260 |
# |
# |
|a New York, NY :
|b Springer New York :
|b Imprint: Springer,
|c 2016.
|
| 300 |
|
|
|a XV, 288 p. 54 illus., 53 illus. in color. :
|b online resource.
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 490 |
1 |
|
|a Cancer Genetics,
|
| 505 |
0 |
|
|a Biology of Melanoma -- The Role of the Immune System and Immunoregulatory Mechanisms Relevant to Melanoma -- Epidemiology and Clinical Characteristics of Melanoma -- Pathology of Melanoma -- Inherited Gene Mutations in Melanoma -- The MAPK Pathway in Melanoma -- The PI3K-AKT Pathway in Melanoma -- Biomarker Analysis for BRAF, NRAS, KIT, and BAP-1 Expression in Melanoma -- Molecular Platforms in Melanoma Mutation Analysis -- Immunotherapy in Melanoma -- Molecular Targeted Therapy in Melanoma -- Dermatologic Toxicities to Melanoma Targeted Therapy.
|
| 650 |
|
0 |
|a Human genetics.
|
| 650 |
|
0 |
|a Cancer research.
|
| 650 |
|
0 |
|a Molecular biology.
|
| 650 |
1 |
4 |
|a Human Genetics.
|
| 650 |
2 |
4 |
|a Cancer Research.
|
| 650 |
2 |
4 |
|a Molecular Medicine.
|
| 700 |
1 |
|
|a Torres-Cabala, Carlos A.
|e editor.
|
| 700 |
1 |
|
|a Curry, Jonathan L.
|e editor.
|
| 710 |
2 |
|
|a SpringerLink (Online service)
|
| 773 |
0 |
|
|t Springer eBooks
|